Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Fetotoxicity, antiangiogenic drugs, nursing considerations and
FGF-1
FGF-2 Application Of The Hallmarks Of Cancer Invasion and Metastasis Targeting Angiogenesis
FGFR,
Fibroblast growth factor (FGF) Application Of The Hallmarks Of Cancer Bone Metastasis Pharmacologic Management Targeting Angiogenesis
Fibroblast growth factor receptor
Fibroblasts Application Of The Hallmarks Of Cancer Glossary Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2) Targeting Angiogenesis
Fibronectin fragment
FIGF Glossary Targeting Angiogenesis
Filopodia Glossary Invasion and Metastasis References References (Chapter 3) Targeting Angiogenesis
Financial issues, targeted therapies and
FISH,
Fissures, EGFRI rash and nurse recommendations for
FLEX trial
Fluorescence in situ hybridization Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) References (Chapter 2)
Fluorometholone
Folkman, J.
Fong, P. C.
Food and Drug Administration Antiangiogenic Drug Therapy Bone Metastasis Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Encouraging Patient Adherence and Persistence Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Epigenetics Nursing Considerations and Drug Information Protein Kinase Inhibitors
Fosamax
Fosbretabulin (Zybrestat) Antiangiogenic Drug Therapy Hypoxia-Inducible Factor, Mtor, and Angiogenesis
FOXC2
FTIs,
G/S checkpoint Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Mitotic Kinase Inhibitors
Gaps Application Of The Hallmarks Of Cancer Targeting Angiogenesis
Gastric cancer, EGFR overexpression in Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Gastrointestinal perforation, antiangiogenic drugs, nursing considerations and
Gastrointestinal stromal tumor
Gastrulation, in the embryo, with germ layers
GDC-0449 Protein Kinase Inhibitors Protein Kinase Signaling Pathways